About (E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid
(E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid (PubChem CID 123413597) has the molecular formula C40H43N3O5
and a molecular weight of 645.80 g/mol. Its IUPAC name is (E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid.
Analyze (E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of (E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid?
The IUPAC name of (E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid (CID 123413597) is (E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid.
What is the SMILES notation for (E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid?
The canonical SMILES for (E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid is COc1ccc2c(c1)N(C)CCn1c-2c(C2CCCCC2)c2ccc(C(=O)NC3(C(=O)Cc4ccc(/C=C/C(=O)O)cc4)CCC3)cc21.
What is the InChIKey of (E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid?
The InChIKey is SQTJFWFGPSFIAM-QGOAFFKASA-N. The full InChI is InChI=1S/C40H43N3O5/c1-42-21-22-43-34-24-29(39(47)41-40(19-6-20-40)35(44)23-27-11-9-26(10-12-27)13-18-36(45)46)14-16-31(34)37(28-7-4-3-5-8-28)38(43)32-17-15-30(48-2)25-33(32)42/h9-18,24-25,28H,3-8,19-23H2,1-2H3,(H,41,47)(H,45,46)/b18-13+.
What are the key properties of (E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid?
(E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid has a molecular weight of 645.80 g/mol, XLogP of 7.38, 9 rotatable bonds, 2 hydrogen bond donors, and 6 hydrogen bond acceptors.
Where does this data come from?
All data for (E)-3-[4-[2-[1-[(13-cyclohexyl-3-methoxy-5-methyl-6,7-dihydroindolo[1,2-d][1,4]benzodiazepine-10-carbonyl)amino]cyclobutyl]-2-oxoethyl]phenyl]prop-2-enoic acid is sourced from PubChem (CID 123413597), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).